MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04366cam a22003974i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
15762208 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20201021112709.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
090603s2011 maua b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2009022814 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780763761615 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0763761613 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Modifying agency |
YDX |
| -- |
NLM |
| -- |
DLC |
| Description conventions |
rda |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC683.5.C5 |
| Item number |
C37 2011 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.12075 |
| Edition number |
22 |
| Item number |
C |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Cardiac biomarkers in clinical practice / |
| Statement of responsibility, etc |
edited by James L. Januzzi, Jr. |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Sudbury, Mass. : |
| Name of publisher, distributor, etc |
Jones and Bartlett Publishers, |
| Date of publication, distribution, etc |
[2011] |
| 264 #4 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Date of publication, distribution, etc |
©2011 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xx, 892 pages : |
| Other physical details |
illustrations (some color) ; |
| Dimensions |
21 cm |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section One: Necrosis Markers -- Chapter 1: Biology of Standard Necrosis Markers -- Chapter 2: The Evolution and Revolution of Necrosis Markers in Modern Cardiology for the Diagnosis of Acute Myocardial Infarction -- Chapter 3: Biochemical and Analytical Issues for Cardiac Troponin -- Chapter 4: Utility of Troponin Testing for Risk Stratification and Treatment Decision Making in Acute Coronary Syndromes -- Chapter 5: Use of Cardiac Troponins in ST-Segment Elevation Myocardial Infarction -- Chapter 6: Interpretation of Cardiac Troponin Elevation in Patients with End-stage Renal Disease -- Chapter 7: Necrosis Market Testing in Heart Failure -- Chapter 8: Necrosis Markers in Conditions Other than Acute Coronary Syndromes and Heart Failure -- Chapter 9: Use of Cardiac Necrosis Biomarkers Following PCI or CABG -- Chapter 10: Emerging Biomarkers in Acute Coronoary Syndrome -- Chapter 11: Ischemia Markers -- Section Two: Inflammatory Markers -- Chapter 12: Inflammation and Inflammatory Markers in Cardiovascular Disease: From Bench to Bedside -- Chapter 13: Inflammation in The Development and Complications of Coronary Artery Disease -- Chapter 14: Role of Inflammatory Marker Testing in Acute Coronary Syndromes -- Chapter 15: Role of Inflammatory Biomarkers in heart Failure -- Section Three: Natriuretic Peptides -- Chapter 16: Biology of the Natriuretic Peptides -- Chapter 17: Natriuretic Peptide Testing: Laboratory Considerations -- Chapter 18: Natriuretic Peptides and Structural Heart Disease -- Chapter 19: Population Testing with Natriuretic Peptides -- Chapter 20: Natriuretic Peptide Testing in Symptomatic Primary Care Patients -- Chapter 21: Natriuretic Peptide Testing for Diagnostic Evaluation of Patients with suspected Acute Hearth Failure -- Chapter 22: Natriuretic Peptide Testing for Patients with Acute and Chronic Coronary Disease -- Chapter 23: Natriuretic Peptides and Prognostication: Predicting Outcomes Across the Spectrum of Medical Conditinos -- Chapter 24: Natriuretic peptides for Guidance of Acute and Chronic Heart Failure therapy -- Chapter 25: Natriuretic Peptide Testing in Patients with Renal Disease -- Chapter 26: Emerging Biomarkers of Cardiac Failure -- Section Four: Markers of Thrombosis and Hemostasis -- Chapter 27: Rationale for Clinical Measurement of Markers in Cardiology -- Chapter 28: Markers of Platelet Function and Assessment of Platelet Activation and Aggregation -- Section Five: Lipid Markers -- Chapter 29: Contemporary Interpretation of Lipid Guidelines in Modern Medicine -- Chapter 30: Biomarkers in the Metabolic Syndrome -- Chapter 31: Emerging Lipid-Based Biomarkers -- Section Six: The "-omics": Genomic, Metabolomic, and Protecomic Markers -- Chapter 32: Genetic Biomarkers |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Cardiac Biomarkers in Clinical Practice presents a case based approach to biomarkers in heart diseases including heart failure, ischemic heart disease, and outpatient. Divided into six sections, this book provides physicians and other health care providers with a clear understanding of the role of biomarkers in clinical cardiovascular medicine |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Heart |
| General subdivision |
Diseases |
| -- |
Diagnosis. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Biochemical markers |
| General subdivision |
Diagnostic use. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Clinical chemistry. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Biological Markers. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Cardiovascular Diseases |
| General subdivision |
diagnosis. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Cardiovascular Diseases |
| General subdivision |
prevention & control. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Risk Assessment. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Januzzi, James L. |
| 9 (RLIN) |
33539 |
| Relator term |
author. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Books |
| Source of classification or shelving scheme |
Dewey Decimal Classification |